Search

Search Results

• 

  The new era of anticoagulation: factor XI and XII inhibitors

  Domenico Prisco, Irene Mattioli, Raffaele De Caterina, Alessandra Bettiol

  07-06-2023

  912

  PDF: 429
• 

  Allopurinol-induced acquired von Willebrand syndrome

  Juan Eirís, Marina Suárez-Terrón, Pablo Granados, David Martínez-Campuzano, Ana Rosa Cid, Saturnino Haya, Santiago Bonanad

  25-10-2023

  316

  PDF: 37
• 

  A case of acquired factor XIII deficiency secondary to plasmablastic lymphoma

  Vincenzo Sammartano, Adele Santoni, Elisabetta Zappone, Paola Calzoni, Daniela Fineschi, Eleonora Franceschini, Federico Caroni, Anna Sicuranza, Monica Bocchia, Luca Puccetti

  09-03-2023

  329

  PDF: 196
• 

  Safety of COVID-19 mRNA vaccination in patients with history of acquired hemophilia A: a case series

  Luca Puccetti, Vincenzo Sammartano, Federico Caroni, Margherita Malchiodi, Paola Calzoni, Eleonora Franceschini, Lucrezia Galasso, Monica Bocchia

  17-10-2022

  2141

  PDF: 127
• 

  Tumor necrosis factor superfamily in multiple sclerosis: from pathology to therapeutic implications

  Federica Azzolini, Antonio Bruno, Ettore Dolcetti, Diego Centonze, Fabio Buttari

  03-05-2023

  828

  PDF: 109
• 

  Growing weapons to fight hemophilia

  Pier Mannuccio Mannucci

  23-02-2023

  506

  PDF: 182
• 

  The Von Willebrand factor-ADAMTS-13 axis: a two-faced Janus in bleeding and thrombosis

  Stefano Lancellotti, Monica Sacco, Maira Tardugno, Antonietta Ferretti, Raimondo De Cristofaro

  26-04-2022

  1615

  PDF: 208
• 

  Factor XI inhibitors in adjunct to antiplatelet therapy: the ultimate dual-pathway inhibition?

  Mattia Galli, C. Michael Gibson, Dominick J. Angiolillo

  03-08-2023

  752

  PDF: 262
• 

  Pleiotropic effects of anti-thrombotic therapies: have direct oral anticoagulants any anti-inflammatory effect?

  Anna Maria Gori, Eleonora Camilleri, Alessia Bertelli, Angela Rogolino, Francesca Cesari, Elena Lotti, Tommaso Capobianco, Walther Iannotti, Betti Giusti , Rossella Marcucci

  14-12-2022

  466

  PDF: 158
• 

  Is non-alcoholic fatty liver disease a prothrombotic risk factor?

  Niccolò Bitto, Vincenzo La Mura, Anna Ludovica Fracanzani, Armando Tripodi

  19-05-2023

  363

  PDF: 76
• 

  Milvexian and other drugs targeting Factor XI: a new era of anticoagulation?

  Marco P. Donadini, Walter Ageno

  15-04-2022

  1805

  PDF: 387
• 

  An ecological alliance against air pollution and cardiovascular disease

  Pier Mannuccio Mannucci

  22-03-2022

  1550

  PDF: 161
• 

  It’s definitely time to consider diet in its ultra-processing form as a major risk factor for thrombotic vascular disorders

  Marialaura Bonaccio, Licia Iacoviello, Maria Benedetta Donati

  03-08-2023

  740

  PDF: 92
• 

  Importance of assessment of carotid plaques in the managementof acute ischemic stroke: floating intracarotid plaque

  Marwa Eltemamy, Robert Namushi, Narayanamoorthi Saravanan

  06-09-2023

  281

  PDF: 57
• 

  Association between non-O blood type and early unexplained recurrent spontaneous abortion in women with and without inherited thrombophilia

  Anna Poretto, Elisabetta Borella, Giacomo Turatti, Michelangelo Marobin, Elena Campello, Daniela Tormene, Paolo Simioni, Luca Spiezia

  14-11-2022

  848

  PDF: 108